Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b+CD4+ T Cells in the CNS during Progressive EAE
出版年份 2014 全文链接
标题
Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b+CD4+ T Cells in the CNS during Progressive EAE
作者
关键词
-
出版物
PLoS One
Volume 9, Issue 6, Pages e99068
出版商
Public Library of Science (PLoS)
发表日期
2014-06-05
DOI
10.1371/journal.pone.0099068
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Benefits and Detriments of Macrophages/Microglia in Models of Multiple Sclerosis
- (2013) Khalil S. Rawji et al. Clinical & Developmental Immunology
- Epithelial V-Like Antigen Mediates Efficacy of Anti-Alpha4 Integrin Treatment in a Mouse Model of Multiple Sclerosis
- (2013) Erik Wright et al. PLoS One
- The discovery of natalizumab, a potent therapeutic for multiple sclerosis
- (2012) Lawrence Steinman JOURNAL OF CELL BIOLOGY
- Myelin Basic Protein-Specific TCR/HLA-DRB5*01:01 Transgenic Mice Support the Etiologic Role of DRB5*01:01 in Multiple Sclerosis
- (2012) J. A. Quandt et al. JOURNAL OF IMMUNOLOGY
- Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages
- (2012) Daniel R Getts et al. Journal of Neuroinflammation
- Natalizumab strongly suppresses cortical pathology in relapsing–remitting multiple sclerosis
- (2012) F Rinaldi et al. Multiple Sclerosis Journal
- Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE
- (2011) Veit Rothhammer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Anaphylaxis and Mortality Induced by Treatment of Mice with Anti-VLA-4 Antibody and Pertussis Toxin
- (2011) N. Ji et al. JOURNAL OF IMMUNOLOGY
- Role for MyD88, TLR2 and TLR9 but Not TLR1, TLR4 or TLR6 in Experimental Autoimmune Encephalomyelitis
- (2011) S. Miranda-Hernandez et al. JOURNAL OF IMMUNOLOGY
- RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
- (2011) Laura Codarri et al. NATURE IMMUNOLOGY
- The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF
- (2011) Mohamed El-Behi et al. NATURE IMMUNOLOGY
- Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
- (2011) Bahareh Ajami et al. NATURE NEUROSCIENCE
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
- Chronic Progressive Multiple Sclerosis – Pathogenesis of Neurodegeneration and Therapeutic Strategies
- (2010) Dirk Fitzner et al. Current Neuropharmacology
- Toll-like Receptor 2 Signaling in CD4+ T Lymphocytes Promotes T Helper 17 Responses and Regulates the Pathogenesis of Autoimmune Disease
- (2010) Joseph M. Reynolds et al. IMMUNITY
- Natalizumab prevents the accumulation of cortical lesions in relapsing remitting multiple sclerosis: a preliminary report
- (2010) F. Rinaldi et al. NEUROLOGICAL SCIENCES
- Engagement of Toll‐Like Receptor 2 on CD4+T Cells Facilitates Local Immune Responses in Patients with Tuberculous Pleurisy
- (2009) Xinchun Chen et al. JOURNAL OF INFECTIOUS DISEASES
- CD28− T cells: their role in the age-associated decline of immune function
- (2009) Nan-ping Weng et al. TRENDS IN IMMUNOLOGY
- Characterization of CD8-positive macrophages infiltrating the central nervous system of rats with chronic autoimmune encephalomyelitis
- (2008) Keiko Hiraki et al. JOURNAL OF NEUROSCIENCE RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started